poisar

Stocks · News reference

KeyBanc Upgrades Maravai LifeSciences to Overweight

Fiscal.ai

KeyBanc Capital Markets has upgraded Maravai LifeSciences Holdings, Inc. from Sector Weight to Overweight, setting a price target of $11.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaBenzinga Insights

    Full Transcript: Maravai LifeSciences Q2 2026 Earnings Call

    Maravai LifeSciences (NASDAQ:MRVI) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by